期刊文献+

肝癌血管生成与抗血管生成治疗的研究进展 被引量:10

Advances of Study on Angiogenesis and Antiangiogenic Therapy in Hepatocellular Carcinoma
下载PDF
导出
摘要 目的介绍肝癌血管生成的分子机理及抗血管生成在肝癌发展与治疗中的作用与意义。方法复习相关文献资料并作综述。结果肝癌血管生成在肝癌的发生与发展中具有重要意义,抗血管生成能有效地阻碍肝癌的发展和转移,可为临床肝癌治疗提供新的途径。结论了解肝癌血管生成的分子机理及应用抗血管生成治疗对肝癌的防治将有积极的意义。 Objective To introduce the possible effects and significances of angiogenesis and antiangiogenic in the development and treatment of hepatocellular carcinoma(HCC).Methods Recently relevant literatures were reviewed.Results Angiogenesis played a significant role in the development and therapy of HCC,and the development and metastasis of HCC could be effectively suppressed by antiangiogenic therapy.This might provide a new approach for the treatment of HCC.Conclusion Comprehending the molecular mechanism of angiogenesis and applying antiangiogenic therapy will contribute a lot for the prevention and treatment of HCC.
作者 叶义标 陈涛
出处 《中国普外基础与临床杂志》 CAS 2009年第10期861-865,共5页 Chinese Journal of Bases and Clinics In General Surgery
基金 广东省科技厅科技计划项目资助(项目编号:E00200603 2005B30301018)~~
关键词 肝细胞肝癌 血管生成 抗血管生成治疗 转移 Hepatocellular carcinoma Angiogenesis Antiangiogenic therapy Metastasis
  • 相关文献

参考文献8

二级参考文献68

  • 1Bing-Hui Yang, Jing-Lin Xia, Li-Wen Huang, Zhao-You Tang, Ming-Shan Chen, Jin-Qing Li, An-Min Liang, Qin-Guo Mo, Hui-Shan Lu, Chao-Liu Dai, Lu-Nan Yan, Zhi-Jian Yu, Rong-Sheng Rao, Le-Qun Li, Zhi-Xiong Su, Zhuang-Wei Fang Shanghai, China Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai 200032, China,Tumor Hospital, Zhongshan University, Guangzhou 510000, China Tumor Hospital, Guangxi Medical Universi- ty, Nanning 530000, China,Xiehe Hospital, Fujian Medical University, Fuzhou 350000, China,Second Hos- pital, Chinese Medical University, Shenyang 110000, China ,Huaxi Hospital, Sichuan University, Chengdu 610041, China ,Hospital Affiliated to Nantong Medical University, Nantong 226000 , China,Second Hospital, Jiangxi Medical University, Nanchang 330000 , China ,First Hospital Affiliated to Guangxi Medical University, Nanning 530000 , China ,People’s Hospital of Hainan Province, Haikou 570000, China.Changed clinical aspects of primary liver cancer in China during the past 30 years[J].Hepatobiliary & Pancreatic Diseases International,2004,3(2):194-198. 被引量:20
  • 2Dong-ShengHuang Ke-ZhenShen Jian-FengWei Thng-BoLiang Shu-SenZheng Hai-YangXie.Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2[J].World Journal of Gastroenterology,2005,11(2):204-207. 被引量:31
  • 3Melchiorre Cervello,Daniela Foderà,Ada Maria Florena,Maurizio Soresi,Claudio Tripodo,Natale D'Alessandro,Giuseppe Montalto.Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: Possible role in tumor promotion and angiogenesis[J].World Journal of Gastroenterology,2005,11(30):4638-4643. 被引量:21
  • 4Zhi-Zhen Dong,Deng-Fu Yao,Deng-Bing Yao,Xin-Hua Wu,Wei Wu,Li-Wei Qiu,Dao-Rong Jiang,Jian-Hua Zhu,Xian-Yong Meng.Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(30):4655-4660. 被引量:45
  • 5张建国,步星耀,张永福,朱贤立.促血管生成素表达与人脑胶质瘤血管生成的关系研究[J].肿瘤防治杂志,2005,12(19):1472-1475. 被引量:1
  • 6[1]Ciardiello F,Caputo R,Bianco R,et al.Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa),a selective epidermal growth factor receptor tyrosine kinase inhibitor.Clin Cancer Res,2001,7:1459
  • 7[2]Bruns C J,Solorzano CC,Harbison MT,et al.Blockade of the epidermal growth factor receptor signaling by a novel tyrosine ki nase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.Cancer Res,2000,60:2926
  • 8[3]Wedge SR,Ogilvie DJ,Dukes M,et al.ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis,and tumor growth following oral administration.Cancer Res,2002,62:4645
  • 9[4]Wedge SR,Ogilvie,Dukes M,et al.Pharmacological efficacy of ZD6474,aVEGF receptor tyrosine kinase inhibitor,in rat. (Abstract) Proceedings of the 92nd Annal Meeting of the Ameri cian Association for Cancer Research,New Orleans (LA), 2001,42:Abst3126,583
  • 10[5]Wedge SR,Checkley D,Tessier JJ,et al.Dynamic contrast -enhanced MRI study of human xenografts treated with the VEGF signaling inhibitor ZD6474.Proceedings of the 92nd Annu al Meeting of the American Association for Cancer Research, New Orleans (LS),2001,42:Abst 581,107

共引文献151

同被引文献122

引证文献10

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部